Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan Weng

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Journal of Oncology|May 16, 2020
Identification of a Gene-Related Risk Signature in Melanoma Patients Using Bioinformatic ProfilingJing Wang, Peng-Fei Kong, Hai-Yun Wang, et al.
ACS Medicinal Chemistry Letters|May 26, 2018
Discovery of Orally Bioavailable Selective Inhibitors of the Sodium-Phosphate Cotransporter NaPi2a (SLC34A1)Kevin J Filipski, Matthew F Sammons, Samit K Bhattacharya, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 14, 2023
Improving the Accuracy and Efficiency of Abnormal Cervical Squamous Cell Detection With Cytologist-in-the-Loop Artificial IntelligencePeng Xue, Hai-Miao Xu, Hong-Ping Tang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 2, 2022
<b>Transporter-Enzyme Interplay in the Pharmacokinetics of PF-06835919, A First-in-class Ketohexokinase Inhibitor for Metabolic Disorders and Non-alcoholic Fatty Liver Disease</b>Yan Weng, Kari R Fonseca, Yi-An Bi, et al.
The Journal of Pathology|October 26, 2018
ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastomaQian Chen, Hai-Yan Weng, Xiao-Peng Tang, et al.
Cell Metabolism|March 10, 2016
A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic SubjectsSaswata Talukdar, Yingjiang Zhou, Dongmei Li, et al.
Scientific Reports|March 11, 2018
Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous DosingYan Weng, Tetsuya Ishino, Annette Sievers, et al.
Nature Communications|April 13, 2025
Deep learning enabled liquid-based cytology model for cervical precancer and cancer detectionPeng Xue, Le Dang, Ling-Hua Kong, et al.
Molecular Metabolism|March 5, 2021
Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunctionJemy A Gutierrez, Wei Liu, Sylvie Perez, et al.
The Journal of Biological Chemistry|February 2, 2020
Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney diseaseXiaotian Zhong, Srinath Jagarlapudi, Yan Weng, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Journal of Oncology|May 16, 2020
Identification of a Gene-Related Risk Signature in Melanoma Patients Using Bioinformatic ProfilingJing Wang, Peng-Fei Kong, Hai-Yun Wang, et al.
ACS Medicinal Chemistry Letters|May 26, 2018
Discovery of Orally Bioavailable Selective Inhibitors of the Sodium-Phosphate Cotransporter NaPi2a (SLC34A1)Kevin J Filipski, Matthew F Sammons, Samit K Bhattacharya, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 14, 2023
Improving the Accuracy and Efficiency of Abnormal Cervical Squamous Cell Detection With Cytologist-in-the-Loop Artificial IntelligencePeng Xue, Hai-Miao Xu, Hong-Ping Tang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 2, 2022
<b>Transporter-Enzyme Interplay in the Pharmacokinetics of PF-06835919, A First-in-class Ketohexokinase Inhibitor for Metabolic Disorders and Non-alcoholic Fatty Liver Disease</b>Yan Weng, Kari R Fonseca, Yi-An Bi, et al.
The Journal of Pathology|October 26, 2018
ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastomaQian Chen, Hai-Yan Weng, Xiao-Peng Tang, et al.
Cell Metabolism|March 10, 2016
A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic SubjectsSaswata Talukdar, Yingjiang Zhou, Dongmei Li, et al.
Scientific Reports|March 11, 2018
Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous DosingYan Weng, Tetsuya Ishino, Annette Sievers, et al.
Nature Communications|April 13, 2025
Deep learning enabled liquid-based cytology model for cervical precancer and cancer detectionPeng Xue, Le Dang, Ling-Hua Kong, et al.
Molecular Metabolism|March 5, 2021
Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunctionJemy A Gutierrez, Wei Liu, Sylvie Perez, et al.
The Journal of Biological Chemistry|February 2, 2020
Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney diseaseXiaotian Zhong, Srinath Jagarlapudi, Yan Weng, et al.
Pageof 15